ly 293558 has been researched along with Absence Status in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Apland, JP; Aroniadou-Anderjaska, V; Braga, MF; Figueiredo, TH; Rossetti, K | 1 |
| Apland, JP; Aroniadou-Anderjaska, V; Braga, MFM; De Araujo Furtado, M; Figueiredo, TH | 1 |
| Apland, JP; Aroniadou-Anderjaska, V; Braga, MFM; Figueiredo, TH; Olsen, CH; Prager, EM | 1 |
| Apland, JP; Aroniadou-Anderjaska, V; Braga, MFM; Figueiredo, TH; Pidoplichko, VI; Rossetti, K | 1 |
| Apland, JP; Aroniadou-Anderjaska, V; Braga, MF; Figueiredo, TH | 1 |
| Almeida-Suhett, CP; Apland, JP; Aroniadou-Anderjaska, V; Braga, MF; Figueiredo, TH; Miller, SL; Prager, EM | 1 |
1 review(s) available for ly 293558 and Absence Status
| Article | Year |
|---|---|
Targeting the glutamatergic system to counteract organophosphate poisoning: A novel therapeutic strategy.
Topics: Animals; Anticonvulsants; Cholinesterase Inhibitors; Humans; Isoquinolines; Nerve Agents; Neuroprotective Agents; Organophosphate Poisoning; Rats; Receptors, AMPA; Receptors, Kainic Acid; Soman; Status Epilepticus; Tetrazoles | 2020 |
5 other study(ies) available for ly 293558 and Absence Status
| Article | Year |
|---|---|
Delayed tezampanel and caramiphen treatment but not midazolam protects against long-term neuropathology after soman exposure.
Topics: Animals; Anticonvulsants; Brain; Brain Injuries; Female; Male; Midazolam; Nerve Agents; Rats; Seizures; Soman; Status Epilepticus | 2023 |
Electroencephalographic analysis in soman-exposed 21-day-old rats and the effects of midazolam or LY293558 with caramiphen.
Topics: Animals; Antidotes; Cyclopentanes; Electrocardiography; Isoquinolines; Male; Midazolam; Nerve Agents; Rats; Rats, Sprague-Dawley; Soman; Status Epilepticus; Tetrazoles | 2020 |
Susceptibility to Soman Toxicity and Efficacy of LY293558 Against Soman-Induced Seizures and Neuropathology in 10-Month-Old Male Rats.
Topics: Amygdala; Animals; Cholinesterase Inhibitors; Hippocampus; Isoquinolines; Male; Nerve Degeneration; Neuropathology; Rats, Sprague-Dawley; Seizures; Status Epilepticus; Tetrazoles | 2017 |
Comparing the Antiseizure and Neuroprotective Efficacy of LY293558, Diazepam, Caramiphen, and LY293558-Caramiphen Combination against Soman in a Rat Model Relevant to the Pediatric Population.
Topics: Animals; Anticonvulsants; Anxiety; Basolateral Nuclear Complex; Behavior, Animal; Child; Cyclopentanes; Diazepam; Disease Models, Animal; Drug Interactions; Humans; Isoquinolines; Male; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Soman; Status Epilepticus; Tetrazoles | 2018 |
A rat model of nerve agent exposure applicable to the pediatric population: The anticonvulsant efficacies of atropine and GluK1 antagonists.
Topics: Acetylcholinesterase; Animals; Anticonvulsants; Atropine; Chemical Warfare Agents; Cholinesterase Inhibitors; Disease Models, Animal; Hippocampus; Isoquinolines; Male; Nerve Degeneration; Oximes; Random Allocation; Rats; Rats, Sprague-Dawley; Receptors, Kainic Acid; Seizures; Soman; Status Epilepticus; Tetrazoles | 2015 |